Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)

This study has been terminated.
(Slow accrual.)
Sponsor:
Collaborator:
Wake Forest School of Medicine
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00074750
First received: December 19, 2003
Last updated: February 20, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2004
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)